Jewel Sylvester
Family · Virginia Beach, VANPI 1104565266
Payments from drug & device makers
Across 120 payments — averaging $26.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$612
- ANI Pharmaceuticals, Inc.$329
- GSK$328
- Amgen$269
- Takeda Pharmaceuticals U.S.A., Inc.$182
- Mallinckrodt Hospital Products Inc.$181
- plus $1K from 16 others
What the payments were for
- Food & beverage$2,95194%
- Education$1806%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 14 | $612 |
| ANI Pharmaceuticals, Inc. | 12 | $329 |
| GSK | 19 | $328 |
| Amgen | 10 | $269 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $182 |
| Mallinckrodt Hospital Products Inc. | 6 | $181 |
| Regeneron Healthcare Solutions, Inc. | 6 | $173 |
| Boehringer Ingelheim | 7 | $169 |
| Actelion Pharmaceuticals US, Inc. | 4 | $152 |
| Genentech USA, Inc. | 4 | $113 |
| Paratek Pharmaceuticals, Inc. | 5 | $90 |
| Jazz Pharmaceuticals Inc. | 3 | $89 |
| Merck | 3 | $88 |
| Baxter Healthcare | 3 | $70 |
| Grifols USA, LLC | 3 | $67 |
| Sanofi | 3 | $66 |
| Mylan Specialty L.p. | 3 | $42 |
| Pharming Healthcare, Inc. | 2 | $32 |
| Inspire Medical Systems, Inc. | 1 | $30 |
| Inogen, Inc. | 1 | $19 |
| Electromed, Inc. | 1 | $16 |
| Harmony Biosciences LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,131 in reported general payments places this provider in the 85th percentile of 4,332 family providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 254 | $280,796 |
| OfevNintedanib Esylate | 17 | $220,056 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 99 | $123,565 |
| Spiriva RespimatTiotropium Bromide | 75 | $79,542 |
| XolairOmalizumab | 15 | $68,548 |
| Dupixent SyringeDupilumab | 12 | $44,904 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 46 | $31,592 |
| Advair HfaFluticasone Propion/Salmeterol | 36 | $24,113 |
| Breo ElliptaFluticasone/Vilanterol | 39 | $24,089 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 21 | $15,544 |
| DuleraMometasone/Formoterol | 11 | $8,258 |
| Pirfenidone | 11 | $8,050 |
| Spiriva HandihalerTiotropium Bromide | 13 | $7,598 |
| Incruse ElliptaUmeclidinium Bromide | 15 | $7,072 |
| Bevespi AerosphereGlycopyrrolate/Formoterol Fum | 11 | $6,615 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Incruse Ellipta, Arnuity Ellipta | $328 | $332,436348 claims |
| Boehringer IngelheimOfev, Spiriva Respimat, Stiolto Respimat | $169 | $331,191138 claims |
| AstraZenecaBreztri Aerosphere, Bevespi Aerosphere, Symbicort | $612 | $136,377130 claims |
| MerckDulera | $88 | $8,25811 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,332 family providers in Virginia.
Other family in Virginia Beach
- Andrea CottonVirginia Beach$696K
- Rachel KingVirginia Beach$51K
- Laura JacksonVirginia Beach$22K
- Kim PhamVirginia Beach$13K
- Joseph BowmanVirginia Beach$11K
- Susan MooreWytheville$438K
- Ellen WermterCharlottesville$251K
- Dana StallingsFranklin$225K
- Jocelyn BrackettHerndon$199K
- Hochong Smith GillesRichmond$131K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.